CME Corner

This activity has expired. CME/CE credit is no longer available and the following content may not be available or may not be up-to-date. For a list of current activities that offer CME/CE credit, click here.

Program Detail

Release Date: December-18-14
Credit Expiration Date: December-18-15


Connie Newman, MD
Adjunct Associate Professor of Medicine
Division of Endocrinology, Diabetes & Metabolism
New York University School of Medicine
New York, NY

Kaye-Eileen Willard, MD
President, Midwest Lipid Association
Medical Director, Chronic Disease Management
Wheaton Franciscan Healthcare, All Saints
Racine WI

Credit Hours

CME: 1.0 AMA PRA Category 1 CreditsTM
ACPE: 1.1 contact hours
ANCC: 1.1 contact hours



Program Description

This educational activity will provide an overview of hypertriglyceridemia, with a focus on:
• Lipoprotein metabolism, including TRLs and remnant cholesterol
• Risks of triglyceride elevation, including pancreatitis and atherosclerotic CVD
• Genetic and secondary causes of triglyceride elevation
• Lifestyle and pharmacologic strategies directed toward clinical management of patients with high triglycerides
• Enabling attainment of LDL-C and non-HDL-C targets
• New and emerging therapies for hypertriglyceridemia

Program Developer/Facilitator


Target Audience

This activity is designed to meet the needs of physicians, physician assistants, pharmacists, registered nurses, nurse practitioners, advance practice registered nurses and registered dietitians with an interest in lipid management.

Learning Objectives

Upon completion of this knowledge-based educational activity, the participant should be able to:

  1. Identify the risks of cardiovascular disease and/or pancreatitis in patients with elevated triglycerides
  2. Explain the importance of treating both LDL-C and non-HDL-C in patients with elevated triglycerides.
  3. Identify secondary causes of hypertriglyceridemia
  4. Develop treatment plans for patients with elevated triglycerides to achieve LDL-C and non-HDL-C targets both through lifestyle modification and drug therapy.
  5. Discuss the benefits and risks of emerging therapeutic approaches for the management of hypertriglyceridemia

    At the conclusion of this activity, Registered Nurses and Nurse Practitioners should be able to provide appropriate care and counsel for patients and their families.


Dr. Newman discloses that she has held stock in Pfizer (which has been sold), and that her husband has consulted for Esperion.
Dr. Willard discloses that she has consulted for Merck & Co., Inc.

NLA planners and managers have nothing to disclose.

PIM planners and managers, Laura Excell, ND, NP, MS, MA, LPC, NCC, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CCMEP, Jan Schultz, RN, MSN, CCMEP, and Patricia Staples, MSN, NP-C, CCRN, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

MCM Education planners and managers have nothing to disclose.

Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclosure Declaration
It is the policy of NLA to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflict of interest is resolved by NLA prior to accreditation of the activity. NLA planners and reviewers have no relevant financial relationships to disclose.

Credit Statements

CME Credit provided by the National Lipid Association

The National Lipid Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The National Lipid Association designates this enduring internet activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
NCCPA accepts AMA PRA Category 1 Credits™ from organizations accredited by ACCME.

The National Lipid Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). CDR Credentialed Practitioners will receive 1 Continuing Professional Education Units (CPEUs) for completion of this activity. CDR Accredited Provider #NL0002.

CE Credit provided by Postgraduate Institute for Medicine

Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Session I- Universal Activity Number 0809-9999-14-228-H01-P (Application)
Postgraduate Institute for Medicine designates this continuing education activity for 1.10 contact hour(s) (.110 CEUs) of the Accreditation Council for Pharmacy Education

This educational activity for 1.1 contact hours is provided by the Postgraduate Institute for Medicine.
Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This educational activity is designated for 0.3 contact hours of pharmacotherapy credit for Advance Practice Registered Nurses.

Statements of credit will be awarded based on the participant's successful completion of the post-test with a score of 55% or better and the completion of the activity evaluation form. If you have questions about this CME/CE activity, please contact the NLA at Please claim credit by December 18, 2015.

For Pharmacists: Upon successfully completing the post-test with a score of 55% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.

To contact Postgraduate Institute for Medicine, please visit

Commercial Support Statements

This activity is supported by an educational grant from AstraZeneca.


Minimum System Requirements
• Pentium III, 600 MHz or Equivalent Processor • 512 MB of RAM • Windows XP, Vista, or 7 • Mac OS X • 800x600 Monitor Resolution • 16-bit Color • 16 bit Sound Card with Speakers

  1. After the activity has finished, click on the "Post-test" button.
  2. Instructions for completing and submitting the post-test and evaluation are provided on the post-test screen.
  3. Please turn off all pop-up blockers to ensure access to the educational activity.
  4. Click on the "Start program" icon at the bottom of this page. If you are not already registered as a user of this website, this will bring you to the login/registration page where you will be able to register as a new member or check existing registration information. When ready, click on the "Continue to Program" icon at the bottom of the screen.
  5. The activity will take approximately 1 hour to complete.

Certificate Fee



This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. The NLA specifically disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through reader’s misunderstanding of content.

By clicking START PROGRAM I acknowledge that I have read the CME/CE information above.

Main Menu